Erratum: Varied immune response to FVIII: Presence of proteolytic antibodies directed to factor VIII in different human pathologies (Clinical Reviews in Allergy and Immunology DOI: 10.1007/s12016-009-8116-3);Varied immune response to FVIII: Presence of proteolytic antibodies directed to factor VIII in different human pathologies

Clinical Reviews in Allergy and Immunology

Volumn 37, Issue 2, 2009, Pages 97-104

  Wootla, Bharath ^a,b,c   Desirazu, Narasimha Rao ^d   Friboulet, Alain ^e   Uda, Taizo ^f   Lacroix Desmazes, Sébastien ^a,b,c   Kaveri, Srini V ^a,b,c  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d INDIAN INSTITUTE OF SCIENCE   (India)

^e UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^f OITA UNIVERSITY   (Japan)

Author keywords

Anti FVIII antibodies; Catalytic antibody; Factor VIII

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 9; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ASTHMA; AUTOIMMUNE DISEASE; BREAST MILK; CATALYSIS; CELL ACTIVATION; CHRONIC ALLOGRAFT NEPHROPATHY; COMPLEMENT FIXATION; EFFECTOR CELL; ENZYME ACTIVITY; HASHIMOTO DISEASE; HEMOPHILIA; HEMOPHILIA A; HUMAN; HYDROLYSIS; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS; MULTIPLE MYELOMA; MULTIPLE SCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; SCLERODERMA; SEPSIS; THROMBOCYTOPENIA;

ANTIBODIES, CATALYTIC; AUTOIMMUNE DISEASES; COMMUNICABLE DISEASES; FACTOR VIII; HUMANS; HYDROLYSIS; IMMUNE SYSTEM PROCESSES; IMMUNOGLOBULIN G; INFLAMMATION; NEOPLASMS;

EID: 70349254138     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-009-8138-x     Document Type: Erratum

References (61)

1. S Ehrenforth W Kreuz I Scharrer, et al. 1992 Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs Lancet 339 594 598 1347102 10.1016/0140-6736(92)90874-3 1:STN:280:DyaK387mslOhsg%3D%3D
2. R De Biasi A Rocino ML Papa E Salerno L Mastrullo D De Biasi 1994 Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates Throm Haemost 7 5 544 547
3. AC Goodeve I Williams GL Bray IR Peake 2000 Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group Thromb Haemost 83 844 848 10896236 1:CAS:528:DC%2BD3cXkslOhtb0%3D
4. B Gail Macick 1993 Treatment of factor VIII inhibitors: products and strategies Seminars in Thromb Heamost 86 192
5. EG Bovill SL Burns EA Golden 1985 Factor VIII antibody in a patient with mild haemophilia Br J Haematol 61 323 328 3929830 10.1111/j.1365-2141.1985. tb02832.x 1:STN:280:DyaL28%2FgtVCgsA%3D%3D
6. E Santagostino A Gringeri L Tagliavacca PM Mannucci 1995 Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin Thromb Haemost 74 619 621 8584995 1:CAS:528:DyaK2MXnvFKqtb8%3D
7. R Lottenburg T Kentro C Kitchins 1987 Acquired hemophilia. A natural history study of 16 patients with FVIII inhibitors reveiving little or no therapy Arch Intern Med 147 1077 1081 10.1001/archinte.147.6.1077 (Pubitemid 17113272)
8. CM Kessler 2000 Acquired factor VIII autoantibody inhibitors: current concepts and potential therapeutic strategies for the future Haematologica 85 57 61 11187873 1:CAS:528:DC%2BD3cXptVegsLc%3D
9. M Franchini G Gandini T Di Paolantonio G Mariani 2005 Acquired hemophilia A: a concise review Am J Hematol 80 55 63 16138334 10.1002/ajh.20390 1:CAS:528:DC%2BD2MXhtVyhtrjE (Pubitemid 41254270)
10. PW Collins S Hirsch TP Baglin, et al. 2006 Acquired haemophilia A in the UK: a two year national surveillance study by UK Haemophilia Centre Doctors' Organisation Blood 109 5 1870 1877 17047148 10.1182/blood-2006-06-029850
11. S Shapiro 1967 The immunologic character of acquired inhibitors of antihemophiliac globulin (Factor VIII) and the kinetics of their interaction with FVIII J Clin Invest 46 147 156 6018754 1:CAS:528:DyaF2sXksFSltQ%3D%3D
12. Gilles J-G, Saint-Remy J-M (1996) Coagulation factor VIII autoantibodies. In: Peter JB, Shoenfeld Y (eds) Autoantibodies. Elsevier, Amsterdam, pp 172-178
13. HA Perkins MR MacKenzie HH Fudenberg 1970 Hemostatic defects in dysproteinemias Blood 35 695 707 4986530 1:STN:280:DyaE3c7ovFSmsQ%3D%3D
14. PR Kelsey MJ Leyland 1982 Acquired inhibitor to human factor VIII associated with paraproteinaemia and subsequent development of chronic lymphatic leukaemia Br Med J (Clinical research ed) 285 174 175 10.1136/bmj.285.6336.174 1:STN:280:DyaL383jt1yjsg%3D%3D
15. D Green K Lechner 1981 A survey of 215 non-hemophilic patients with inhibitors to factor VIII Thromb Haemastos 45 3 200 203 1:STN:280: DyaL38%2FhvVWlsw%3D%3D
16. AE Morrison CA Ludlam C Kessler 1993 Use of porcine factor VIII in the treatment of patients with acquired hemophilia Blood 81 1513 1520 8453098 1:STN:280:DyaK3s3gtVGisg%3D%3D
17. D Green J Blanc N Foiles 1999 Spontaneous inhibitors of factor VIII: kinetics of inactivation of human and porcine factor VIII J Lab Clin Med 133 260 264 10072258 10.1016/S0022-2143(99)90082-3 1:CAS:528:DyaK1MXitVShtrk%3D (Pubitemid 29112088)
18. RK Pruthi WL Nichols 1999 Autoimmune factor VIII inhibitors Curr Opin Hematol 6 314 322 10468147 10.1097/00062752-199909000-00008 1:STN:280: DyaK1Mzps1ahsQ%3D%3D (Pubitemid 30763595)
19. M Algiman G Dietrich U Nydegger D Boieldieu Y Sultan MD Kazatchkine 1992 Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals Proc Natl Acad Sci U S A 89 3795 3799 1570298 10.1073/pnas.89.9.3795 1:CAS:528:DyaK38XktVGktrg%3D
20. JG Gilles J Arnout J Vermylen JM Saint-Remy 1993 Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction Blood 82 2452 2461 7691260 1:CAS:528:DyaK2cXms1aq
21. G Dietrich M Algiman Y Sultan UE Nydegger MD Kazatchkine 1992 Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg) Blood 79 2946 2951 1586740 1:CAS:528:DyaK38XkvVyntLs%3D
22. JG Gilles B Desqueper H Lenk J Vermylen JM Saint-Remy 1996 Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A J Clin Invest 97 1382 1388 8617869 10.1172/JCI118558 1:CAS:528:DyaK28XhvVensLs%3D
23. Y Sultan MD Kazatchkine P Maisonneuve UE Nydegger 1984 Anti-idiotypic suppression of autoantibodies to Factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin Lancet 2 765 768 6148519 10.1016/S0140-6736(84)90701-3 1:STN:280:DyaL2M%2FhtFGquw%3D%3D
24. F Rossi Y Sultan MD Kazatchkine 1988 Anti-idiotypes against autoantibodies and alloantibodies to Factor VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins Clin Exp Immunol 74 311 316 3147154 1:STN:280:DyaL1M7js1ejuw%3D%3D
25. CA Fulcher S De Graaf Mahoney JR Roberts CK Kasper TS Zimmerman 1985 Localization of human factor VIII inhibitor epitopes to two polypeptide fragments Proc Natl Acad Sci U S A 82 7728 7732 2415970 10.1073/pnas.82.22.7728 1:CAS:528:DyaL28XksVGq (Pubitemid 16204422)
26. R Kalaga L Li JR O'Dell S Paul 1995 Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis J Immunol 155 2695 2702 7650397 1:CAS:528: DyaK2MXnsFyns70%3D
27. S Paul L Lan R Kalaga, et al. 1997 Characterization of thyroglobulin-directed and polyreactive catalytic antibodies in autoimmune disease J Immunol 159 1530 1536 9233652 1:CAS:528:DyaK2sXkslOqs7g%3D
28. S Planque Y Bangale XT Song, et al. 2004 Ontogeny of proteolytic immunity: IgM serine proteases J Biol Chem 279 14 14024 14032 14726510 10.1074/jbc.M312152200 1:CAS:528:DC%2BD2cXis1elt7w%3D (Pubitemid 38468937)
29. Y-Y Kit DV Semenov GA Nevinsky 1996 Phosphorylation of different human milk proteins by human catalytic secretory immunoglobulin A Biochem Molec Biol Intl 39 521 527 1:CAS:528:DyaK2sXlvValtg%3D%3D
30. TG Kanyshkova DV Semenov D Khlimankov VN Buneva GA Nevinsky 1997 DNA-hydrolyzing activity of the light chain of IgG antibodies from milk of healthy human mothers FEBS Lett 416 23 26 9369225 10.1016/S0014-5793(97)01163-0 1:CAS:528:DyaK2sXms1eksrc%3D (Pubitemid 27470793)
31. JP Wentworth JE McDunn AD Wentworth, et al. 2002 Evidence of antibody-catalyzed ozone formation in bacterial killing and inflammation Science 298 2195 2199 12434011 10.1126/science.1077642 1:CAS:528:DC%2BD38XpsVSktLo%3D (Pubitemid 35471245)
32. A Friboulet B Avalle H Debat D Thomas 1999 A possible role of catalytic antibodies in metabolism Immunol Today 20 474 475 10500296 10.1016/S0167- 5699(99)01528-5 1:CAS:528:DyaK1MXmsVertL0%3D (Pubitemid 29476078)
33. AM Shuster GV Gololobov OA Kvashuk AE Bogomolova IV Smirnov AG Gabibov 1992 DNA hydrolyzing autoantibodies Science 256 665 667 1585181 10.1126/science.1585181 1:CAS:528:DyaK38XisFerur0%3D
34. A Vlassov C Florentz M Helm, et al. 1998 Characterization and selectivity of catalytic antibodies from human serum with RNase activity Nucleic Acids Res 26 5243 5250 9826744 10.1093/nar/26.23.5243 1:CAS:528:DyaK1MXis1Clug%3D%3D
35. AG Baranovskii NA Ershova VN Buneva, et al. 2001 Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis Immunol Lett 76 163 167 11306143 10.1016/S0165-2478(01)00185-7 1:CAS:528:DC%2BD3MXisF2ktro%3D (Pubitemid 32295936)
36. L Li S Paul S Tyutyulkova MD Kazatchkine S Kaveri 1995 Catalytic activity of anti-thyroglobulin antibodies J Immunol 154 3328 3332 7897215 1:CAS:528:DyaK2MXks1Ogsbs%3D
37. S Lacroix-Desmazes J Bayry SV Kaveri, et al. 2005 High levels of catalytic antibodies correlate with favorable outcome in sepsis Proc Natl Acad Sci U S A 102 4109 4113 15743915 10.1073/pnas.0500586102 1:CAS:528: DC%2BD2MXis12jtrY%3D (Pubitemid 40388563)
38. S Lacroix-Desmazes J Bayry N Misra, et al. 2002 The prevalence of proteolytic antibodies against factor VIII in hemophilia A N Engl J Med 346 662 667 11870243 10.1056/NEJMoa011979 1:CAS:528:DC%2BD38XhsFOjsr0%3D (Pubitemid 34815870)
39. S Lacroix-Desmazes A Moreau Sooryanarayana, et al. 1999 Catalytic activity of antibodies against factor VIII in patients with hemophilia A Nat Med 5 044 1047 10.1038/12483 (Pubitemid 29439576)
40. B Wootla S Dasgupta JD Dimitrov, et al. 2008 Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia J Immunol 180 7714 7720 18490775 1:CAS:528:DC%2BD1cXmtVamsLs%3D
41. B Wootla A Nicoletti N Patey, et al. 2008 Hydrolysis of coagulation factors by circulating IgG is associated with a reduced risk for chronic allograft nephropathy in renal transplanted patients J Immunol 180 8455 8460 18523313 1:CAS:528:DC%2BD1cXntVeksLo%3D
42. P Thiagarajan R Dannenbring K Matssura A Tramontano G Gololobov S Paul 2000 Monoclonal antibody light chain with prothrombinase activity Biochemistry 39 6459 6465 10828960 10.1021/bi992588w 1:CAS:528:DC%2BD3cXivVWhs7s%3D (Pubitemid 30347151)
43. M Nardi S Tomlinson MA Greco S Karpatkin 2001 Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia Cell 106 551 561 11551503 10.1016/S0092-8674(01)00477-9 1:CAS:528:DC%2BD3MXmvF2muro%3D (Pubitemid 32879317)
44. AA Belogurov Jr IN Kurkova A Friboulet, et al. 2008 Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis J Immunol 180 1258 1267 18178866 1:CAS:528:DC%2BD1cXhsVOquw%3D%3D
45. NA Ponomarenko OM Durova II Vorobiev, et al. 2002 Catalytic antibodies in clinical and experimental pathology: human and mouse models J Immunol Methods 269 197 211 12379362 10.1016/S0022-1759(02)00324-1 1:CAS:528: DC%2BD38XnvVOgu7Y%3D
46. NA Ponomarenko OM Durova II Vorobiev, et al. 2006 Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen Proc Natl Acad Sci U S A 103 281 286 16387849 10.1073/pnas.0509849103 1:CAS:528:DC%2BD28XpsVSnsw%3D%3D (Pubitemid 43122392)
47. S Lacroix-Desmazes B Wootla S Dasgupta, et al. 2006 Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII J Immunol 177 1355 1363 16818797 1:CAS:528:DC%2BD28XmsVarsr0%3D
48. H Holschermann RM Bohle H Zeller, et al. 1999 In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy Am J Pathol 154 211 220 9916935 1:CAS:528:DyaK1MXnsFGisw%3D%3D
49. H Holschermann RM Bohle H Schmidt, et al. 2000 Hirudin reduces tissue factor expression and attenuates graft arteriosclerosis in rat cardiac allografts Circulation 102 357 363 10899102 1:CAS:528:DC%2BD3cXls1Kltbg%3D
50. MH Yen G Pilkington RC Starling, et al. 2002 Increased tissue factor expression predicts development of cardiac allograft vasculopathy Circulation 106 1379 1383 12221056 10.1161/01.CIR.0000028588.73765.B4 1:CAS:528: DC%2BD38XntVKksL4%3D (Pubitemid 35013042)
51. M Matsuyama R Yoshimura K Akioka, et al. 2003 Tissue factor antisense oligonucleotides prevent renal ischemia-reperfusion injury Transplantation 76 786 791 14501854 10.1097/01.TP.0000079630.68668.C2 1:CAS:528: DC%2BD3sXnsVKis7k%3D (Pubitemid 37140220)
52. MH Sayegh CB Carpenter 2004 Transplantation 50 years later-progress, challenges, and promises N Engl J Med 351 2761 2766 15616214 10.1056/NEJMon043418 1:CAS:528:DC%2BD2MXhtFWhtA%3D%3D (Pubitemid 39665333)
53. M Riewald W Ruf 2003 Science review: role of coagulation protease cascades in sepsis Critical Care (London, England) 7 123 129 10.1186/cc1825 (Pubitemid 36432670)
54. RN Salom JA Maguire WW Hancock 1998 Endothelial activation and cytokine expression in human acute cardiac allograft rejection Pathology 30 24 29 9534204 10.1080/00313029800169625 1:STN:280:DyaK1c7psFKqsQ%3D%3D (Pubitemid 28083031)
55. PM Mannucci EG Tuddenham 2001 The hemophilias-from royal genes to gene therapy N Engl J Med 344 1773 1779 11396445 10.1056/NEJM200106073442307 1:CAS:528:DC%2BD3MXkslKqsbo%3D (Pubitemid 32497033)
56. M Arai D Scandella LW Hoyer 1989 Molecular basis of factor VIII inhibition by human antibodies: antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid J Clin Invest 83 1978 1984 2498393 10.1172/JCI114107 1:CAS:528:DyaL1MXksFejtbo%3D
57. EL Saenko M Shima GE Gilbert D Scandella 1996 Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for FVIII inhibition J Biol Chem 271 27424 27431 8910322 10.1074/jbc.271.44.27424 1:CAS:528:DyaK28XmvVWmt78%3D (Pubitemid 26367300)
58. M Shima D Scandella A Yoshioka, et al. 1993 A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine Thromb Haemost 69 240 246 7682339 1:CAS:528: DyaK3sXlslyqs7g%3D
59. D Zhong EL Saenko M Shima M Felch D Scandella 1998 Some human inhibitor antibodies interfere with factor VIII binding to Factor IX Blood 92 136 142 9639509 1:CAS:528:DyaK1cXktleru78%3D
60. PA Foster CA Fulcher RA Huoghten S de Graaf Mahoney TS Zimmerman 1988 Localization of the binding regions of a murine monoclonal anti-FVIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chain J Clin Invest 82 123 128 2839543 10.1172/JCI113559 1:CAS:528:DyaL1cXlsVOmu78%3D
61. BC Lubahn J Ware DW Stafford HM Reisner 1989 Identification of a FVIII epitope recognized by a human hemophilic inhibitor Blood 73 497 499 2465036 1:CAS:528:DyaL1MXhtlensLw%3D